Hartland & Co »

Corvus Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6k 203 7.71

More positions owned by Hartland & Co

Vanguard Index Fds Put Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Value Etf (VTV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Nvidia Corporation Put Put Option (Principal) (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Perceptive Advisors
Foresite Capital Management VI
DCF Advisers
Susquehanna International
Goldman Sachs Group
Logos Global Management

View all funds holding Corvus Pharmaceuticals